Matthew Johnson

Matthew Johnson is an experienced professional in process chemistry, currently serving as Executive Director at Taiho Oncology, Inc. since January 2024. Prior roles include Executive Director of Process Chemistry at Astex Pharmaceuticals from March 2020 to January 2024, and Vice President of Chemical Development at Asymchem Group from March 2017 to February 2020. Additionally, Matthew held positions at Asymchem as Director of Chemical Development and as a Senior Research Scientist II at AMRI, where responsibilities included leading medicinal chemistry projects. Early career experience encompasses a senior chemist role at Biofocus and a postdoctoral position at Queen's University under Professor Victor Snieckus. Educational credentials include a postdoctoral fellowship at Queen's University in metallation and cross-coupling, and a Ph.D. and B.Sc. from the University of Birmingham focusing on combinatorial carbohydrate chemistry.